NFKB1 and neoplasm: Additionally, the modulation of noncanonical NFκB signaling through cIAP1/2 inhibition by LCL161 in a mouse model of pancreatic cancer enhanced macrophage activation, increasing phagocytosis of tumor cells in a T-cell–dependent manner [73].